AzTrials
AzTrials

GingivitisERICONCT04455269

The Efficacy of Full Mouth Erythritol Powder Air-Polishing Therapy (FM-EPAPT) Versus Traditional Ultrasonic Debridment (UD): a Randomized Controlled Study.

A study testing AIRFLOW® with PLUS® powder and PIEZON® scaler and PIEZON® scaler and rubber cup with abrasive paste in people with Gingivitis, run by Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Traditional methods for plaque and calculus removal involve the use of mechanical and/or manual instruments, followed by surface polishing with rubber cups and low abrasive pastes. Read more about this study

Who is it for?
Ages 20 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Gingivitis
What is being tested?
AIRFLOW® with PLUS® powder and PIEZON® scaler and PIEZON® scaler and rubber cup with abrasive paste
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
41 participants
Where
1 siteItaly
Study dates
3 May 2017to 1 Apr 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Diagnosis of gingivitis (BoP > 25%);
  • Presence of at least 5 teeth per quadrant;
  • Systemically healthy;
  • Age between 20 and 40 years old.

Who cannot join

  • Presence of periodontal disease, defined as >3 mm of clinical attachment loss at any site;
  • Presence of fixed retainers, orthodontic appliances or complex prothetic restorations;
  • Presence of crowding;
  • Pregnant or lactating;
  • Allergy to chlorhexidine or erythritol;
  • Smoking >10 cigarettes per day;
  • Unwillingness to undergo the proposed treatment and recalls;

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Magda Mensi

    Brescia, Lombardy, 25123

Other trials in Italy

About this study

Traditional methods for plaque and calculus removal involve the use of mechanical and/or manual instruments, followed by surface polishing with rubber cups and low abrasive pastes. These instruments may cause the unintended removal of hard dental tissue, such as enamel, cementum and dentine, increasing surface roughness. Moreover, they can lead to gingival recession and consequent hypersensitivity and discomfort during treatment. New minimally-invasive approaches to biofilm removal have been recently introduced with the aim to limit the negative impact on the oral tissue. Air-polishing with low-abrasiveness powders are proven suitable for both for supra- and sub-gingival plaque removal. The use of low-abrasiveness powders could lead to several advantages, such as reduction of treatment discomfort, shorter treatment time, the possibility of cleaning areas with difficult access and minor damage on soft and hard tissues.

Aim: the aim of this study is to evaluate the efficacy of the Full Mouth Erithrytol Powder Air-Polishing Therapy compared to traditional ultrasonic debridment (UD) and polishing in patient affected by gingivitis.

Read more

Test hypotesis: there is no difference in clinical outcome between two methods against the hypothesis of a difference in terms of changes in Blending on Probing (BOP).

To test this hypothesis, the patients, upon initial evaluation, were treated in split mouth:

  • The control group undergoing the standard procedure with full-mouth ultrasonic debridement and polishing with rubber cup and abrasive paste.
  • The study group undergoing an innovative procedure involving full-mouth air-polishing followed by ultrasonic calculus removal.

Follow-ups are scheduled at 2 weeks and 1, 3, 6 and 12 months.

Read the detailed description

TRIAL DESIGN:

Mono-centric, pragmatic, double-blinded, randomized clinical trial (RCT) with split-mouth design. The trial will have a one year of duration.

PRIMARY OUTCOME:

  • Change in BoP: change in percentage of sites positive to bleeding on probing.

SECONDARY OUTCOMES:

  • Change in Plaque Index (PI): change in percentage of sites with presence of plaque. Baseline values will be compared to the values recorded at follow-up visits.
  • Change in Residual Plaque Area (RPA): Post-treatment percentage of tooth area with residual plaque, visualised via plaque disclosing agent. This will be calculated with computer software analysis (ImageJ) on clinical photographs.
  • Change in Periodontal Attachment Level (PAL): change in mean value for each patient will be calculated. Baseline values will be compared to the values recorded at follow-up visits.
  • Change in (Pocket Probing Depth) PPD: change in mean value for each patient will be calculated. Baseline values will be compared to the values recorded at follow-up visits.
  • Duration of the treatment: calculated in minutes. Time will be recorded starting from the opening the randomisation envelope until the clinician is satisfied with the clinical result.
  • Comfort of the patient: an anonymous questionnaire will be administered at baseline and each recall appointment.
  • Sensation of cleanliness: an anonymous questionnaire will be administered at baseline and each recall appointment.

STUDY POPULATION:

41 Systemically healthy patients affected by gingivitis will be included in this study. Presence of gingivitis is defined as: absence of Probing pocket depth (PPD) > 4mm and presence of BoP >25%.

INCLUSION CRITERIA:

  • Patients affected by gingivitis (BoP >25%);
  • Patients with at least 5 teeth per quadrant;
  • Systemically healthy;
  • Age > 18 years;
  • Smoking less than 10 cigarettes a day.
Conditions
Gingivitis
Being tested
AIRFLOW® with PLUS® powder and PIEZON® scaler, PIEZON® scaler and rubber cup with abrasive paste
Keywords
Gingivitis, GBT, Ultrasonic debridement
Medical subject headings
Gingivitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AIRFLOW® with PLUS® powder and PIEZON® scalerDevice

    Air-polishing will be use as main instrument for biofilm and stains removal, followed by ultrasonic scaling

  • PIEZON® scaler and rubber cup with abrasive pasteDevice

    Application of ultrasonic scaler on the entire dentition, followed by residual biofilm and stains removal and polishing

Study groups in NCT04455269
Study groupRoleWhat they receive
Full-Mouth Erythritol Powder Air-polishing Therapy (FM-EPAPT)ExperimentalThe quadrants allocated to FM-EPAPT underwent the following steps: * Decontamination of soft tissues with air-polishing and erythritol powder; * Supra-gingival removal biofilm with air-polishing and erythritol powder; * Sub-gingival removal of biofilm with air-polishing and erythritol; * Calculus removal with a piezoceramic scaler.
Receives: Device: AIRFLOW® with PLUS® powder and PIEZON® scaler
Ultrasonic debridement and abrasive paste (US+P)Active comparatorThe quadrants allocated to US+P treatment underwent the following steps: * Full-mouth ultrasonic debridement with piezoceramic scaler; * Plaque removal and polishing with soft rubber cup and low-RDA polishing paste
Receives: Device: PIEZON® scaler and rubber cup with abrasive paste

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Bleeding on Probing (BoP)

    Change in percentage of sites positive to bleeding on probing

    Measured: study completion, an average of 18 months

Secondary outcomes (7)
  1. Change in Plaque Index (PI)

    Change in percentage of site with plaque. Baseline values will be compared to the values recorded in the follow-up visits.

    Measured: From baseline to study completion (12 months)

  2. Change in residual plaque area (RPA)

    Post-treatment residual plaque recorded via plaque disclosing agent, clinical photographs and image software analysis

    Measured: From baseline to study completion (12 months)

  3. Change in Periodontal Attachment Level (PAL)

    Change in mean PAL value for each patient should be calculated. Baseline values will be compared to the values recorded in the follow-up visits.

    Measured: From baseline to study completion (12 months)

  4. Change in Pocket Probing Depth (PPD)

    Change in mean PPD value for each patient. Baseline values will be compared to the values recorded in the follow-up visits.

    Measured: From baseline to study completion (12 months)

  5. Treatment time

    Calculated in minutes, from the opening of the randomisation envelope to the end of the instrumentation.

    Measured: From baseline to study completion (12 months)

  6. Comfort of the patient

    An anonymous questionnaire will be administered at baseline and each recall appointment. The score is on a scale: from 0 to 5, where 0 is the minimum discomfort and 5 the maximum discomfort.

    Measured: From baseline to study completion (12 months)

  7. Sensation of cleanliness

    An anonymous questionnaire will be administered at baseline and each recall appointment. The score is on a scale of 5 feelings: insufficient, sufficient, average, good and optimal.

    Measured: From baseline to study completion (12 months)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jul 2020
  2. Study start3 May 2017
  3. Primary completion1 Apr 2019
  4. Study completion1 Apr 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Mono-centric, double-blinded, randomized clinical trial (RCT) with a split-mouth design.
Masking
Single blind
Who is masked
Investigator
Enrolment
41 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04455269
Sponsor's protocol ID
ERICO np: 2637
Acronym
ERICO
Status last verified
Jul 2020
First submitted
29 Jun 2020
Last updated
15 Jul 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Draenert ME, Jakob M, Kunzelmann KH, Hickel R. The prevalence of tooth hypersensitivity following periodontal therapy with special reference to root scaling. A systematic review of the literature. Am J Dent. 2013 Feb;26(1):21-7.

    PubMed 23724545
  • Buhler J, Amato M, Weiger R, Walter C. A systematic review on the patient perception of periodontal treatment using air polishing devices. Int J Dent Hyg. 2016 Feb;14(1):4-14. doi: 10.1111/idh.12119. Epub 2015 Jan 23.

    PubMed 25619863
  • Flemmig TF, Arushanov D, Daubert D, Rothen M, Mueller G, Leroux BG. Randomized controlled trial assessing efficacy and safety of glycine powder air polishing in moderate-to-deep periodontal pockets. J Periodontol. 2012 Apr;83(4):444-52. doi: 10.1902/jop.2011.110367. Epub 2011 Aug 23.

    PubMed 21861637
  • Camboni S, Donnet M. Tooth Surface Comparison after Air Polishing and Rubber Cup: A Scanning Electron Microscopy Study. J Clin Dent. 2016 Mar;27(1):13-18.

    PubMed 28390211
  • Kim SY, Kang MK, Kang SM, Kim HE. Effects of ultrasonic instrumentation on enamel surfaces with various defects. Int J Dent Hyg. 2018 May;16(2):219-224. doi: 10.1111/idh.12339. Epub 2018 Mar 13.

    PubMed 29532597

Questions about this trial

What is this clinical trial studying?

A study testing AIRFLOW® with PLUS® powder and PIEZON® scaler and PIEZON® scaler and rubber cup with abrasive paste in people with Gingivitis, run by Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Jul 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Bleeding on Probing (BoP) (time frame: study completion, an average of 18 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04455269, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jul 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in